Period of time： 2014年5期
Publisher： Informa Healthcare
Founded in： 1992
Total resources： 167
ISSN： 1354-3784
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Investigational Drugs,volume 20,issue 5
Menu
From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer
By Góómez-Raposo Céésar,Mendiola Marta,Barriuso Jorge,Hardisson David,Redondo Andréés in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.
Access to resources
Recommend
New targeted therapies for gastric cancer
By Asaoka Yoshinari,Ikenoue Tsuneo,Koike Kazuhiko in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer
By Buck Elizabeth,Mulvihill Mark in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.The Syk kinase as a therapeutic target in leukemia and lymphoma
By Efremov Dimitar G,Laurenti Luca in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.Angiogenesis-related molecular targets in esophageal cancer
By Hong Liu,Li Shujun,Han Yu,Du Jianjun,Zhang Hongwei,Li Jipeng,Zhao Qingchuan,Wu Kaichun,Fan Daiming in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.HIF prolyl hydroxylase inhibitors for anemia
By Muchnik Eugene,Kaplan Joshua in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.Lysophosphatidic acid-1-receptor targeting agents for fibrosis
By Rancoule Chloéé,Pradèère Jean-Philippe,Gonzalez Julien,Klein Julie,Valet Philippe,Bascands Jean-Loup,Schanstra Joost P,Saulnier-Blache Jean-Séébastien in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.Novel agents for diffuse large B-cell lymphoma
By Sinha Rajni,DeJoubner Nutan,Flowers Christopher in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.By Steed Helen L,Chu Quincy S-C in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.Pomalidomide therapy for myeloma
By Schey Stephen,Ramasamy Karthik in (2011)
Expert Opinion on Investigational Drugs,volume 20,issue 5 , Vol. 20, Iss. 5, 2011-05 , pp.
Previous
Next